papers/w3a-patent-acquisition.tex

\documentclass[11pt,a4paper]{article}
\usepackage{shared/luxcover}
\usepackage[utf8]{inputenc}
\usepackage[T1]{fontenc}
\usepackage{amsmath,amssymb}
\usepackage{graphicx}
\usepackage{hyperref}
\usepackage{booktabs}
\usepackage{enumitem}
\usepackage{xcolor}
\usepackage{tabularx}

\hypersetup{colorlinks=true,linkcolor=black,citecolor=blue,urlcolor=blue}

\title{W3A Foundation\\[4pt]
\large Investor Memorandum: Acquisition of U.S.\ Patent 11,803,853
and Consolidation of the Post-Quantum IP Portfolio}

\author{
Lux Research\thanks{Corresponding author: [email protected]}\\
\textit{Lux Industries, Inc.}\\
\texttt{[email protected]}
}

\date{July 2026 \quad|\quad CONFIDENTIAL --- NOT FOR DISTRIBUTION}

\begin{document}

\luxcoverpage

\begin{abstract}
\noindent Lux Industries proposes to acquire the patent family anchored by
U.S.\ Patent No.\ 11,803,853~B2 (``Controlling transactions on a
network'') from Nahmii~AS of Bergen, Norway, and to place it --- together
with all Lux post-quantum cryptography filings --- in a single
wholly-owned IP holding entity, the \textbf{W3A Foundation}. The family
carries a May~2018 priority date, three granted patents (two U.S., one
European), a clean chain of title, no encumbrances of record, and
roughly thirteen years of remaining term. Its claims sit at the
transaction-control layer that every Layer-2 network, cross-chain
bridge, and threshold-custody flow passes through; Lux's post-quantum
portfolio sits at the signature layer beneath it. Held together, the two
layers form a defensive moat and a licensing surface neither provides
alone.
\end{abstract}

\tableofcontents
\newpage

%% ============================================================
\section{Executive Summary}

\begin{itemize}[leftmargin=1.4em]
  \item \textbf{Target asset.} The ``Controlling transactions on a
  network'' family (inventor Mark Briscombe): US~11,803,853~B2,
  US~12,586,073~B2, and EP~3\,788\,757~B1, all granted, priority
  4~May~2018, expiring on or about 6~May~2039.
  \item \textbf{Seller.} Nahmii~AS (org.\ nr.\ 991482741, Bergen,
  Norway; formerly Hubii~AS). Active and solvent per the Norwegian
  business registry --- this is a negotiated purchase from a going
  concern, not a distressed sale.
  \item \textbf{Status.} All three patents in force. Title of record is
  clean; no security interests, litigation, or post-grant challenges
  found. The family was extended as recently as 24~March~2026, when the
  U.S.\ continuation granted --- the seller has kept it alive and
  current.
  \item \textbf{Structure.} The family is acquired by, and all Lux
  post-quantum patents and applications are assigned into, the W3A
  Foundation --- a new IP holding entity wholly owned by Lux
  Industries, Inc. Operating entities take a perpetual intra-group
  license back.
  \item \textbf{Near-term obligation.} The first U.S.\ maintenance fee
  on the '853 patent falls due in the window opening 31~October~2026.
  The acquirer must docket it at closing.
\end{itemize}

%% ============================================================
\section{The Asset}

\subsection{Patent family}

\begin{table}[h]
\centering
\small
\begin{tabularx}{\textwidth}{@{}llllX@{}}
\toprule
\textbf{Right} & \textbf{Application} & \textbf{Granted} & \textbf{Status} & \textbf{Notes}\\
\midrule
GB 1807389.0 & filed 2018-05-04 & --- & priority & Root priority filing\\
PCT/EP2019/061595 & filed 2019-05-06 & --- & ceased & WO\,2019/211494; national phase complete\\
US 11,803,853 B2 & 17/052{,}944 & 2023-10-31 & in force & National-stage entry 2020-11-04\\
US 12,586,073 B2 & 18/384{,}566 & 2026-03-24 & in force & Continuation of 17/052{,}944\\
EP 3\,788\,757 B1 & 19722865.3 & granted & in force & Validated states to be confirmed\\
\bottomrule
\end{tabularx}
\caption{The '853 family. Both U.S.\ patents share the 20-year term
measured from the PCT filing date: expiry on or about 6~May~2039
(subject to any patent-term adjustment and terminal disclaimers, to be
confirmed in diligence). Approximately 12.8 years of term remain.}
\end{table}

\subsection{What the claims cover}

The specification describes, and the claims recite, a network
architecture in which transaction \emph{origination} is separated from
transaction \emph{execution}, with execution gated on independent
validation:

\begin{enumerate}[leftmargin=1.6em]
  \item User nodes originate transactions through a server rather than
  directly against the chain.
  \item \textbf{Validator nodes} independently verify both the
  \emph{completeness} of transaction data (defeating data-withholding
  attacks) and its \emph{correctness} (defeating fraud).
  \item An \textbf{oracle} (second agent) is queried for the validation
  outcome; a \textbf{smart contract} (first agent) permits execution
  only on a passing result.
  \item Covered transaction types include deposit, payment, settlement,
  withdrawal, and balance requests conducted over state channels, with
  remedial actions (pause, suspend, terminate, alert) on detected
  fraud.
\end{enumerate}

Two properties give the family its weight. First, the \textbf{priority
date}: May~2018 predates the deployment of essentially every modern
rollup, optimistic or validity-based, every production cross-chain
bridge, and every oracle-gated settlement system now in use. Second,
the \textbf{grant record}: the EPO --- which does not grant abstract
business methods --- allowed the European counterpart, which supports
the technical character of the claims and is a meaningful (though not
dispositive) comfort signal against U.S.\ \S101 challenges.

%% ============================================================
\section{Status and Chain of Title}

This section answers the threshold question: where does the asset stand
today, and who can sell it.

\subsection{Ownership}

\begin{itemize}[leftmargin=1.4em]
  \item \textbf{Owner of record:} Nahmii~AS, Bergen, Norway.
  \item \textbf{Chain of title:} inventor Mark Briscombe
  $\rightarrow$ Hubii~AS (assignment recorded 19~November~2020)
  $\rightarrow$ Nahmii~AS (change of name recorded 28~February~2023).
  The 2023 event is a renaming of the same legal entity, not a
  transfer --- the corporate lineage in the Norwegian registry is
  Mapitall~AS (2007) $\rightarrow$ Hubii~AS (2011) $\rightarrow$
  Nahmii~AS (2021), one org number throughout.
  \item \textbf{Encumbrances:} no security interests, licenses, or
  liens appear in the public legal-events record. To be confirmed
  against the USPTO Assignment database and EPO register at diligence.
\end{itemize}

\subsection{Seller condition}

Nahmii~AS is registered active: not bankrupt, not under voluntary or
compulsory liquidation. The company is a Series-A Ethereum Layer-2
infrastructure firm (roughly \$8M raised) and was selected by Norges
Bank for its experimental CBDC sandbox. Two consequences for deal
posture:

\begin{itemize}[leftmargin=1.4em]
  \item There is no distress discount to harvest. Price discovery will
  be a negotiation with a functioning management team that recently
  spent money extending the family (the March~2026 continuation grant).
  \item The seller will almost certainly require a \textbf{license back}
  for its own L2 operations. This is acceptable: the strategic value to
  Lux is defensive coverage and portfolio anchoring, not excluding
  Nahmii.
\end{itemize}

\subsection{Maintenance posture}

\begin{itemize}[leftmargin=1.4em]
  \item \textbf{US '853:} first maintenance fee (3.5-year) window opens
  31~October~2026; due 30~April~2027, surcharge period to
  31~October~2027. \emph{This is the first post-closing docket item.}
  \item \textbf{US '073:} first maintenance fee due 2029.
  \item \textbf{EP '757:} annual annuities in each validated state;
  current status per state to be confirmed.
  \item \textbf{Litigation / post-grant:} no district-court cases, ITC
  actions, IPRs, or PGRs located. Formal docket and PTAB searches are a
  diligence item.
\end{itemize}

%% ============================================================
\section{Strategic Rationale}

\subsection{Two layers, one moat}

Lux's post-quantum work protects the \emph{signature layer}: threshold
ML-DSA (Pulsar), R-LWE threshold signing (Corona), threshold SLH-DSA
(Magnetar), the Quasar post-quantum consensus family, on-chain
post-quantum verification precompiles (P3Q), and GPU-native
verification. The '853 family protects the \emph{control layer} above
it: validator-gated, oracle-verified transaction execution --- the
architectural pattern through which every L2 sequencer, bridge
attestation, and MPC-custody withdrawal actually flows.

A post-quantum signature portfolio alone invites the response
``design around the scheme.'' A transaction-control patent alone
invites ``design around the oracle.'' Held together under one entity,
they cover both what signs and what gates --- and the 2018 priority
date of '853 backstops the whole position in a way no new filing can
reproduce.

\subsection{Uses}

\begin{enumerate}[leftmargin=1.6em]
  \item \textbf{Defensive.} Freedom-to-operate insurance and
  counter-assertion mass for Lux Network, its bridges, and MPC custody.
  Foundation ownership insulates the operating companies from direct
  exposure of the crown-jewel IP.
  \item \textbf{Licensing surface.} The foundation can run a standard
  program: royalty-free defensive pledges to the open-source ecosystem,
  commercial terms for proprietary L2/bridge operators. The EPO grant
  gives the program credibility in Europe.
  \item \textbf{Portfolio anchor.} A granted 2018-priority family
  materially raises the floor value of the consolidated portfolio
  versus a collection of young, application-stage PQ filings.
\end{enumerate}

%% ============================================================
\section{Holding Structure: W3A Foundation}

\begin{itemize}[leftmargin=1.4em]
  \item \textbf{Entity.} W3A Foundation, wholly owned by Lux
  Industries, Inc. To make ``wholly owned'' legally exact, the
  recommended form is a foundation company with Lux Industries as sole
  member (or, equivalently, a conventional IP-holdco subsidiary bearing
  the Foundation name). Formation has not yet occurred; no public
  registration exists as of this memo. Entity formation is a
  condition precedent to closing.
  \item \textbf{Consolidation.} At or promptly after closing:
  (i)~the '853 family assigns from Nahmii~AS to W3A;
  (ii)~all Lux post-quantum patents, applications, and invention
  disclosures assign from their current holders into W3A;
  (iii)~all assignments are recorded at the USPTO and EPO.
  \item \textbf{Operating licenses.} W3A grants a perpetual,
  irrevocable, royalty-bearing (or capital-contribution-offset)
  license to Lux operating entities; external licensing runs through
  the foundation exclusively. One entity, one licensing surface, one
  place to diligence --- and one place for a future acquirer or
  investor to value.
\end{itemize}

%% ============================================================
\section{Transaction and Valuation Frame}

No price has been discussed with the seller; the figures below are a
pre-diligence working frame, not an offer basis.

\begin{itemize}[leftmargin=1.4em]
  \item \textbf{Comparables.} Granted blockchain-infrastructure
  families with U.S.\ + EP coverage and 10+ years of term have
  historically cleared in the mid-six to low-seven figure range (USD)
  in negotiated sales; single-patent lots without EP counterparts trade
  materially lower. The March~2026 continuation grant and the 2018
  priority date argue for the upper half of that band; the absence of
  any enforcement history argues for the lower half.
  \item \textbf{Structure.} Cash at closing for the assignment, plus a
  royalty-free, non-transferable grant-back to Nahmii~AS limited to its
  own operated networks. Avoid earn-outs tied to enforcement --- they
  entangle the seller in future assertion decisions.
  \item \textbf{Cost basis after closing.} Maintenance and annuities
  across the family run low four figures annually in the near term
  (rising at the 7.5- and 11.5-year U.S.\ marks); diligence,
  recordation, and transfer costs are one-time and modest relative to
  purchase price.
\end{itemize}

%% ============================================================
\section{Risk Factors}

\begin{enumerate}[leftmargin=1.6em]
  \item \textbf{\S101 (Alice) exposure.} U.S.\ claims directed to
  transaction control carry inherent abstract-idea risk. Mitigants:
  claims recite a concrete network architecture (validator nodes,
  oracle, execution gating), and the EPO granted the counterpart. Risk
  is real but priced into the valuation band.
  \item \textbf{Prior art.} The 2016--2018 state-channel and plasma
  literature (Lightning, Raiden, Plasma) is the natural invalidity
  hunting ground. An invalidity-grade prior-art search is required
  \emph{before} an offer is priced, not after.
  \item \textbf{Family may be closed.} If Nahmii filed no further
  continuation before the '073 grant on 24~March~2026, no new U.S.\
  claims can be pursued (a broadening reissue of '073 remains available
  until 24~March~2028). Whether a continuation is pending is a
  first-order diligence question --- an open family is worth
  meaningfully more.
  \item \textbf{Design-arounds.} The claims require the
  validator/oracle interplay as recited; architectures that collapse
  validation into the execution contract may avoid them. Value
  accordingly rests on the portfolio position and priority date, not on
  any single unavoidable claim.
  \item \textbf{EP validation gaps.} The European patent may be
  validated (or still in force) in fewer states than assumed; annuity
  lapses shrink the European position.
  \item \textbf{Enforcement reality.} Asserting against decentralized
  networks is structurally hard (who is the infringer?). The thesis
  here is defensive depth and licensing, not assertion revenue ---
  investors should not underwrite litigation upside.
\end{enumerate}

%% ============================================================
\section{Diligence Plan and Next Steps}

\begin{enumerate}[leftmargin=1.6em]
  \item \textbf{Title and encumbrance:} full USPTO Assignment Search
  and EPO register pull; confirm no liens, exclusive licenses, or
  springing interests; obtain the Briscombe inventor-assignment
  instruments.
  \item \textbf{Family completeness:} USPTO Patent Center review for
  pending continuations, terminal disclaimers, and patent-term
  adjustment on both U.S.\ patents; EP register for validated states
  and annuity status.
  \item \textbf{Validity:} commissioned invalidity-grade prior-art
  search over 2015--2018 state-channel, sidechain, and oracle
  literature; \S101 opinion from U.S.\ counsel.
  \item \textbf{Adversarial record:} PTAB, district-court, and ITC
  docket sweeps for any challenge or assertion history.
  \item \textbf{Seller engagement:} approach Nahmii~AS through
  Norwegian counsel; establish whether IP monetization is on their
  agenda and whether the grant-back structure lands.
  \item \textbf{Entity formation:} form W3A Foundation with Lux
  Industries, Inc.\ as sole member; open the docketing calendar with
  the 31~October~2026 '853 maintenance window as the first entry.
  \item \textbf{Consolidation:} execute and record the intra-group
  assignments of the Lux post-quantum portfolio into W3A concurrently
  with closing.
\end{enumerate}

\vspace{1.5em}
\noindent\textit{Sources: USPTO / Google Patents records for
US\,11{,}803{,}853\,B2, US\,12{,}586{,}073\,B2, WO\,2019/211494\,A1, and
EP\,3\,788\,757\,B1; Norwegian Business Registry
(Br{\o}nn{\o}ysundregistrene) entity 991482741. All patent-office facts
verified July 2026; diligence items flagged above remain open.}

\end{document}